Annual report pursuant to Section 13 and 15(d)

ACCRUED EXPENSES

v3.23.1
ACCRUED EXPENSES
12 Months Ended
Dec. 31, 2022
Payables and Accruals [Abstract]  
ACCRUED EXPENSES

Note 5. ACCRUED EXPENSES

 

Accrued expenses at December 31, 2022 and 2021, are summarized below:

SCHEDULE OF ACCRUED EXPENSES 

    2022     2021  
    December 31,  
    2022     2021  
             
Compensation   $ 340,680     $ 277,185  
Legal and professional     144,440       166,069  
Clinical     50,922       39,481  
Other     5,852       766  
Total accrued expenses   $ 541,894     $ 483,501  

 

 

bioAffinity Technologies, Inc.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2022 and 2021